New UK Model Agreements To Streamline Clinical Research
Executive Summary
Efforts are on to reduce the time it takes to set up commercial studies in UK hospitals.
You may also be interested in...
Pharma Industry Urges UK To Make Good On Its Clinical Trial Promises
Research-based drug companies are asking for swift implementation of UK clinical trial reforms to ensure the country does not lose out on commercial trial activity amid challenges such as capacity constraints in the NHS and delays in regulatory approvals.
UK Focuses On Recovering Non-COVID-19 Research
The UK government has set aside over £64m ($89m) to support the first phase of activities to be undertaken in the coming months under a two-part initiative to strengthen clinical research delivery.
Pharma Welcomes UK-Wide Applicability Of Revised Model Clinical Trials Agreement
The pharmaceutical industry has welcomed the UK's updated model clinical trials agreement that sponsors can now use to rapidly sign off contracts when undertaking clinical trials in hospitals run by the national health services throughout the country.